Avadel Phrmctcls ADR (AVDL)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK DUBLIN, IRELAND 15

Avadel Pharmaceuticals plc is a specialty pharmaceutical company. The Company develops products by acquiring and in-licensing new products. Avadel Pharmaceuticals markets products in primary care and sterile injectables markets.

Data as of 2020-09-12
Market Cap308.569 Million Shares Outstanding58.221 Million Avg 30-day Volume946.489 Thousand
P/E Ratio36.1 Dividend Yield EPS-0.56
Price/Sales6.488 Price cash flow ratio16.6 Price free cash flow ratio-16.3
Book Value3.13 Price to Tangible Book2.03 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.039009
BETA0.985426 52-week High/Low13.49 / 2.1 Stddev0.231599
View SEC Filings from AVDL instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 1 (0.07%) 2 (0.13%) -50.0%
Funds Holding: 73 57 28.07% 36 (2.35%) 24 (1.53%) 50.0%
13F shares: 36.273 Million 26.86 Million 35.05% 27.98 Million 18.948 Million 47.67%
% Ownership 62.4014 57.8818 7.81% 48.1348 40.8332 17.88%
New Positions: 29 24 20.83% 17 10 70.0%
Increased Positions 27 7 285.71% 12 5 140.0%
Closed Positions 12 8 50.0% 5 3 66.67%
Reduced Positions 10 15 -33.33% 4 5 -20.0%
Total Calls 975.2 Thousand 4.476 Million -78.21% 156.8 Thousand 2.303 Million -93.19%
Total Puts 509.16 Thousand 403.342 Thousand 26.24% 434.36 Thousand 225.042 Thousand 93.01%
PUT/CALL Ratio 0.52 0.09 477.78% 2.77 0.1 2670.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AVDL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVDL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

262.8 Thousand total shares from 14 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MCHUGH THOMAS S CHIEF FINANCIAL OFFICER

  • Officer
21,500 2020-09-18 5

ENDE ERIC J

  • Director
84,900 2020-09-17 6

MCCAMISH MARK ANTHONY

  • Director
171,000 2020-09-16 5

GLASS GEOFFREY MICHAEL

  • Director
65,700 2020-08-28 4

PALCZUK LINDA

  • Director
37,900 2020-08-14 3

DIVIS GREGORY J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
99,100 2020-08-12 2

THORNTON PETER J.

  • Director
0 2020-08-07 1

HATTEN SANDRA L SEE REMARKS

  • Officer
59,165 2019-12-12 1

VAUGHN JASON SR. VP, TECHNICAL OPERATIONS

  • Officer
0 2019-11-05 2

KOTLER KEVIN

BROADFIN CAPITAL, LLC

BROADFIN HEALTHCARE MASTER FUND LTD

  • Director
3,130,573 2019-08-07 0

GUSKY DAVID P SEE REMARKS

  • Officer
0 2019-06-30 0

STAPLETON CRAIG R

  • Director
0 2019-05-09 0

DUBOW JORDAN CHIEF MEDICAL OFFICER

  • Officer
0 2019-04-29 0

THOMPSON PHILLANDAS T. SEE REMARKS

  • Officer
113,671 2019-03-07 0

KANAN MICHAEL F SEE REMARKS

  • Officer
50,538 2019-03-07 0

ANDERSON MICHAEL S SEE REMARKS

  • Officer
  • Director
0 2018-12-28 0

VAN ASSCHE BENOIT

  • SEE REMARKS
No longer subject to file 2018-07-18 0

FILDES FRANCIS

  • SEE REMARKS
No longer subject to file 2018-07-18 0

NAVARRE CHRISTOPHE

  • SEE REMARKS
No longer subject to file 2018-07-18 0

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND II, L.P.

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT L.P.

DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.

BREAKING STICK HOLDINGS, LLC

  • 10% Owner
  • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2018-06-25 0

D'SILVA DHIREN VP IRISH & EUROPEAN OPERATIONS

  • Officer
No longer subject to file 2018-02-07 0

MACKE SCOTT A.

  • SEE REMARKS
No longer subject to file 2017-10-10 0

SULLIVAN STEPHEN G.

  • SEE REMARKS
No longer subject to file 2017-10-10 0

DAVIS GREGORY J.

  • SEE REMARKS
No longer subject to file 2017-10-10 0

MONTEITH DAVID

  • SEE REMARKS
No longer subject to file 2017-10-10 0

ELROD MARCUS W

  • SEE REMARKS
No longer subject to file 2017-10-10 0

CERUTTI GUILLAUME

  • SEE REMARKS
No longer subject to file 2017-06-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MCHUGH THOMAS S - Officer CHIEF FINANCIAL OFFICER

2020-09-21 16:01:26 -0400 2020-09-18 P 4,000 $6.00 a 21,500 direct -10.5983 0.0 1 -10.5983 2

MCCAMISH MARK ANTHONY - Director by matthew 5 llc

2020-09-18 16:20:52 -0400 2020-09-17 P 52,398 $5.83 a 171,000 indirect -3.7829 -13.4868 0.0 1 -17.4342 4

ENDE ERIC J - Director

2020-09-18 16:19:01 -0400 2020-09-17 P 17,000 $5.79 a 84,900 direct -3.7829 -13.4868 0.0 1 -17.4342 4

MCCAMISH MARK ANTHONY - Director by matthew 5 llc

2020-09-18 16:20:52 -0400 2020-09-16 P 118,602 $5.73 a 118,602 indirect -3.7829 -13.4868 0.0 1 -17.4342 4

MCCAMISH MARK ANTHONY - Director

2020-09-14 07:17:09 -0400 2020-09-13 A 50,000 a 50,000 direct

GLASS GEOFFREY MICHAEL - Director

2020-09-01 16:11:46 -0400 2020-08-28 P 4,800 $6.78 a 65,700 direct -5.0143 -20.6304 0.0 1 -20.6304 6

MCHUGH THOMAS S - Officer CHIEF FINANCIAL OFFICER

2020-09-01 16:12:15 -0400 2020-08-28 P 7,500 $6.77 a 17,500 direct -5.0143 -20.6304 0.0 1 -20.6304 6

PALCZUK LINDA - Director

2020-08-17 18:58:10 -0400 2020-08-14 P 2,500 $7.94 a 37,900 direct 5.1522 -7.377 5.1522 2 -7.377 6

ENDE ERIC J - Director

2020-08-17 18:57:33 -0400 2020-08-13 P 1,200 $7.74 a 64,100 direct 5.1522 -7.377 5.1522 2 -7.377 6

GLASS GEOFFREY MICHAEL - Director

2020-08-14 18:11:27 -0400 2020-08-13 P 6,500 $7.76 a 60,900 direct 0.1172 -6.6823 5.2755 3 -6.6823 6

ENDE ERIC J - Director

2020-08-17 18:57:33 -0400 2020-08-13 P 3,800 $7.80 a 67,900 direct 5.1522 -7.377 5.1522 2 -7.377 6

MCHUGH THOMAS S - Officer CHIEF FINANCIAL OFFICER

2020-08-17 18:59:29 -0400 2020-08-13 P 10,000 $7.78 a 10,000 direct 5.1522 -7.377 5.1522 2 -7.377 6

ENDE ERIC J - Director

2020-08-13 19:40:14 -0400 2020-08-12 P 15,000 $7.76 a 62,900 direct 7.8382 4.2984 -33.5019 13.5272 4 -36.536 29

GLASS GEOFFREY MICHAEL - Director

2020-08-14 18:11:27 -0400 2020-08-12 P 6,500 $7.70 a 54,400 direct 0.1172 -6.6823 5.2755 3 -6.6823 6

DIVIS GREGORY J - Director - Officer CHIEF EXECUTIVE OFFICER

2020-08-13 19:39:37 -0400 2020-08-12 P 13,000 $7.78 a 99,100 direct 7.8382 4.2984 -33.5019 13.5272 4 -36.536 29

PALCZUK LINDA - Director

2020-08-11 16:56:42 -0400 2020-08-07 A 42,000 a 42,000 direct

GLASS GEOFFREY MICHAEL - Director

2020-08-11 16:57:19 -0400 2020-08-07 A 42,000 a 42,000 direct

MCCAMISH MARK ANTHONY - Director

2020-08-11 16:58:04 -0400 2020-08-07 A 42,000 a 42,000 direct

ENDE ERIC J - Director

2020-08-11 16:56:59 -0400 2020-08-07 A 42,000 a 42,000 direct

THORNTON PETER J. - Director

2020-08-11 16:57:40 -0400 2020-08-07 A 42,000 a 42,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 3.57% 2018-06-08 GERMANY
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 1.34% 2018-06-26 GERMANY
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 3.81% 2018-06-05 GERMANY
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 3.94% 2018-06-01 GERMANY
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 0.99% 2018-08-22 GERMANY
LINDEN ADVISORS LP Avadel Pharmaceuticals plc 0.63% 2018-08-30 GERMANY

Elevate your investments